The impact of long-term treatment with disease modifying therapy on disability progression in relapsing-remitting multiple sclerosis patients

被引：0
|
作者：
Carra, Adriana J. [1 ]
Onaha, Patricia S. [1 ]
Sinay, Vladimiro [2 ]
Halfon, Mario J. [1 ]
机构：
[1] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina
[2] Inst Neurociencias Fdn Favaloro, Buenos Aires, DF, Argentina
来源：
MULTIPLE SCLEROSIS JOURNAL | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Measuring disability progression: the impact of long-term treatment with disease-modifying therapy in relapsing-remitting multiple sclerosis patients
    Carra, A.
    Onaha, P.
    Schweitzer, L.
    Jullier, G. Imhoff
    Sinay, V.
    Vrech, C.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S248 - S248
  • [2] Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
    Dekker, I
    Leurs, C. E.
    Hagens, M. H. J.
    van Kempen, Z. L. E.
    Kleerekooper, I
    Lissenberg-Witte, B., I
    Barkhof, F.
    Uitdehaag, B. M. J.
    Balk, L. J.
    Wattjes, M. P.
    Killestein, J.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 82 - 87
  • [3] Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression
    Barcutean, Laura
    Maier, Smaranda
    Bajko, Zoltan
    Stoian, Adina
    Mosora, Oana
    Sarmasan, Emanuela
    Manescu, Ion-Bogdan
    Balasa, Rodica
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
  • [4] Early predictors of long-term disability progression in relapsing remitting multiple sclerosis patients treated with disease-modifying treatments
    Romeo, M.
    Martinelli, V.
    Rodegher, M.
    Moiola, L.
    Colombo, B.
    Messina, M. J.
    Radaelli, M.
    Comi, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 25 - 25
  • [5] Impact of disease-modifying therapies on long-term disability. An observational study of 1609 relapsing-remitting multiple sclerosis patients: treatment onset before irreversible EDSS 3 delayed disability progression
    Le Page, E
    Leray, E
    Laplaud, DA
    Coustans, M
    Chaperon, J
    Edan, G
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S6 - S6
  • [6] Long-term adherence to interferon β therapy in relapsing-remitting multiple sclerosis
    Portaccio, E.
    Zipoli, V.
    Siracusa, G.
    Sorbi, S.
    Amato, M. P.
    [J]. EUROPEAN NEUROLOGY, 2008, 59 (3-4) : 131 - 135
  • [7] Relapsing-remitting multiple sclerosis: a long-term observation of immunomodulatory therapy
    Romanowski, F
    Straube, E
    Heinemann, J
    Rhein, R
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 152 - 152
  • [8] Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis
    Kalincik, Tomas
    Diouf, Ibrahima
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva
    Trojano, Maria
    Ayuso, Guillermo Izquierdo
    Eichau, Sara
    Onofrj, Marco
    Lugaresi, Alessandra
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Grand'Maison, Francois
    Sola, Patrizia
    Ferraro, Diana
    Shaygannejad, Vahid
    Alroughani, Raed
    Hupperts, R. M. M.
    Terzi, Murat
    Boz, Cavit
    Lechner-Scott, Jeannette
    Cartechini, Elisabetta
    Van Pesch, Vincent
    Iuliano, Gerardo
    Granella, Franco
    Bergamaschi, Roberto
    Fernandez Bolanos, Ricardo
    Spitaleri, Daniele Litterio A.
    Slee, Mark
    Vucic, Ostoja
    Ampapa, Radek
    McCombe, Pamela
    Ramo-Tello, Cristina
    Petersen, Thor
    Verheul, Freek
    Prevost, Julie
    Olascoaga Urtaza, Francisco Javier
    Cristiano, Edgardo
    Butzkueven, Helmut
    [J]. NEUROLOGY, 2020, 94 (15)
  • [9] The real life impact of early versus delayed treatment of interferon beta on long-term disability progression in relapsing-remitting multiple sclerosis
    Trojano, Maria
    Amato, Maria Pia
    Avolio, Carlo
    Bergamaschi, Roberto
    Cavalla, Paola
    Durelli, Luca
    Fuiani, Aurora
    Ghezzi, Angelo
    Lugaresi, Alessandra
    Lus, Giacomo
    Millefiorini, Enrico
    Paolicelli, Damiano
    Patti, Francesco
    Pellegrini, Fabio
    Imbaro, S. Maria
    Pozzilli, Carlo
    Rossi, Paolo
    Salemi, Giuseppe
    Vianello, Marica
    Livrea, Paolo
    Comi, Giancarlo
    [J]. NEUROLOGY, 2008, 70 (11) : A88 - A88
  • [10] Impact of disease-modifying therapy drugs on long term disability. An observational study of 1609 relapsing-remitting multiple sclerosis patients: Treatment onset before irreversible EDSS 3 delayed disability progression
    Laplaud, DA
    Le Page, E
    Leray, E
    Coustans, M
    Chaperon, J
    Edan, G
    [J]. NEUROLOGY, 2005, 64 (06) : A129 - A129
12345